Similar studies in patient cohorts from different ethnic backgrounds are warranted to generalize the conclusion that loss-of-function mutations in the EPHB6 signalling pathway molecules is a relative hypertension risk, and that such risk will only be materialized after testosterone levels are reduced. This evidence concerns the gene EPHB6 and Hypertension.